Clinical Trial: Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Randomized-Withdrawal, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Subjects With Behcet's Disease Uveitis
Brief Summary: The objective of this study is to assess the efficacy and safety of gevokizumab in treating Behcet's disease uveitis (BDU).
Detailed Summary:
Sponsor: XOMA (US) LLC
Current Primary Outcome: Time to first ocular exacerbation [ Time Frame: Randomization through Day 280 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: XOMA (US) LLC
Dates:
Date Received: October 2, 2014
Date Started: November 2014
Date Completion:
Last Updated: December 28, 2015
Last Verified: December 2015